Global burden of antimicrobial resistance: essential pieces of a global puzzle
Lancet
.
2022 Jun 25;399(10344):2347-2348.
doi: 10.1016/S0140-6736(22)00939-4.
Authors
Timothy R Walsh
1
,
Rabaab Zahra
2
,
Kenneth Iregbu
3
,
Sharon J Peacock
4
,
Andrew Stewardson
5
Affiliations
1
Ineos Oxford Institute of Antimicrobial Research, University of Oxford OX1 3RE, Oxford, UK. Electronic address: timothy.walsh@zoo.ox.ac.uk.
2
Department of Microbiology, Quaid-i-Azam University, Islamabad, Pakistan.
3
Department of Clinical Microbiology, National Hospital Abuja, Abuja, Nigeria.
4
Department of Medicine, School of Clinical Medicine, University of Cambridge, Cambridge, UK.
5
Department of Infectious Diseases, The Alfred and Central Clinical School, Monash University, Melbourne, VIC, Australia.
PMID:
35753336
DOI:
10.1016/S0140-6736(22)00939-4
No abstract available
Publication types
Letter
Comment
MeSH terms
Anti-Bacterial Agents* / pharmacology
Anti-Bacterial Agents* / therapeutic use
Drug Resistance, Bacterial*
Humans
Substances
Anti-Bacterial Agents